Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Recombinant porphobilinogen deaminase targeted to the liver corrects enzymopenia in a mouse model of acute intermittent porphyria
Karol M. Córdoba, Irantzu Serrano-Mendioroz, Daniel Jericó, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 627
Open Access | Times Cited: 14

Showing 14 citing articles:

Acute Intermittent Porphyria’s Symptoms and Management: A Narrative Review
Esma Z Kizilaslan, Nitin Ghadge, Andrea Martínez, et al.
Cureus (2023)
Open Access | Times Cited: 14
Exploring current and emerging therapies for porphyrias
Daniel Jericó, Karol M. Córdoba, F Urigo, et al.
Liver International (2024) Vol. 44, Iss. 9, pp. 2174-2190
Closed Access | Times Cited: 4
Preclinical evaluation of AGT mRNA replacement therapy for primary hyperoxaluria type I disease
Taihua Yang, Jiahao Ge, Lei Huang, et al.
Science Advances (2025) Vol. 11, Iss. 15
Closed Access
Recent Insights into the Pathogenesis of Acute Porphyria Attacks and Increasing Hepatic PBGD as an Etiological Treatment
Daniel Jericó, Karol M. Córdoba, Ana Sampedro, et al.
Life (2022) Vol. 12, Iss. 11, pp. 1858-1858
Open Access | Times Cited: 15
Cutting-Edge Therapies and Novel Strategies for Acute Intermittent Porphyria: Step-by-Step towards the Solution
Miriam Longo, Erika Paolini, Marica Meroni, et al.
Biomedicines (2022) Vol. 10, Iss. 3, pp. 648-648
Open Access | Times Cited: 12
Understanding Hepatic Porphyrias: Symptoms, Treatments, and Unmet Needs
Oluwashanu Balogun, Kari Nejak‐Bowen
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 209-225
Open Access | Times Cited: 2
RNA interference therapy in acute hepatic porphyrias
Makiko Yasuda, Sioḃán Keel, Manisha Balwani
Blood (2023) Vol. 142, Iss. 19, pp. 1589-1599
Open Access | Times Cited: 6
Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should Know
Petro E. Petrides
Diagnostics (2022) Vol. 12, Iss. 7, pp. 1618-1618
Open Access | Times Cited: 8
Novel Gene-Correction-Based Therapeutic Modalities for Monogenic Liver Disorders
Mahsa Ghasemzad, Mahdieh Hashemi, Zohre Miri-Lavasani, et al.
Bioengineering (2022) Vol. 9, Iss. 8, pp. 392-392
Open Access | Times Cited: 8
Causal effect of porphyria biomarkers on alcohol-related hepatocellular carcinoma through Mendelian Randomization
Xiaoyu Yang, Shuomin Wang, Chen Sun, et al.
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0299536-e0299536
Open Access | Times Cited: 1
Escherichia coli with increased aminoglycoside resistance due to an amino acid substitution at position 85 of HemC
Tomoki Komeda, Tomomi Hishinuma, Teruo Kirikae, et al.
Journal of Infection and Chemotherapy (2024)
Closed Access | Times Cited: 1
Givosiran: a targeted treatment for acute intermittent porphyria
Amy K. Dickey, Rebecca Karp Leaf
Hematology (2024) Vol. 2024, Iss. 1, pp. 426-433
Closed Access
Mechanistic modelling of enzyme‐restoration effects of new recombinant liver‐targeted proteins in acute intermittent porphyria
Diego Vera‐Yunca, Karol M. Córdoba, Zinnia P. Parra‐Guillén, et al.
British Journal of Pharmacology (2022) Vol. 179, Iss. 14, pp. 3815-3830
Open Access | Times Cited: 1
Photodermatoses: what's new
Margaret E. Scollan, Christine T. Lauren
Current Opinion in Pediatrics (2022) Vol. 34, Iss. 4, pp. 374-380
Closed Access | Times Cited: 1
Page 1

Scroll to top